Number of Shares
-
Current Holdings Value*
N/A
% of Portfolio
0%
Total Estimate Gain
$1.69 Mil
% of Total Estimate Gain
6.47%

Catalio Capital Management, LP's Blueprint Medicines Corp Holding Summary

As of 2025-03-31, Catalio Capital Management, LP held - shares of Blueprint Medicines Corp(BPMC), totaling N/A. This investment constitutes 0% of their stock portfolio, and Catalio Capital Management, LP now holds 0% of the outstanding Blueprint Medicines Corp(BPMC) stock.

The initial trade took place in 2024Q4. In addition, there have been 1 sales at an average price of $97.55 for 284,654.00 shares. Based on historical transaction data and BPMC's current price of $128.40, Catalio Capital Management, LP's estimated gain on his BPMC holdings is $1.69 Mil, reflecting a 6.47% gain to date.

Catalio Capital Management, LP BPMC ($128.40) Holding Chart

Catalio Capital Management, LP BPMC ($128.40) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1